ANTIVIRALES ARZNEIMITTEL ENTHALTEND PROSTRATIN

The present invention relates to an antiviral composition and to methods of treating patients with viral infections. The antiviral composition of the present invention comprises prostratin, a phorbol ester derivative, and a pharmaceutically acceptable carrier. The present composition while having an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	COX, PAUL, A., PROVO, UT 84602, US, BLUMBERG, PETER, M., FREDERICK, MD 21701, US, BEUTLER, JOHN, A., BRADDOCK HEIGHTS, MD 21714, US, SHARKEY, NANCY, A., ROCKVILLE, MD 20850, US, ISHITOYA, JUNICHI, BETHESDA, MD 20814, US, GUSTAFSON, KIRK, R., MOUNT AIRY, MD 21771, US, CRAGG, GORDON, M., BETHESDA, MD 20814, US, WEISLOW, OWEN, S., RESTON, VA 22094, US, MCMAHON, JAMES, B., FREDERICK, MD 21701, US, BOYD, MICHAEL, R., IJAMSVILLE, MD 20852, US, CARDELLINA, JOHN, H., II, WALKERSVILLE, MD 21793, US
Format:	Patent
Sprache:	ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to an antiviral composition and to methods of treating patients with viral infections. The antiviral composition of the present invention comprises prostratin, a phorbol ester derivative, and a pharmaceutically acceptable carrier. The present composition while having antiviral activity does not have substantial tumor promoting activity and does not have other substantial adverse toxicological properties that would preclude its use in antiviral therapy.